Fosun Pharma repurchases shares, holds as treasury

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (HKEX: 2196) announced a share repurchase on April 14, 2025. The company repurchased 1,041,674 ordinary shares on the Shanghai Stock Exchange. The repurchase prices ranged from RMB23.93 to RMB24.03 per share, with an aggregate price paid of RMB24,996,349.04. These repurchased shares will be held as treasury shares. The company also noted that no new shares can be issued, nor can treasury shares be sold or transferred for a specified moratorium period after the repurchase, in accordance with exchange rules.